Nat Clin Pract Cardiovasc Med. 2006;3(7):346-347. Since the first widespread clinical application of left ventricular assist devices (LVADs) for patients with end-stage heart failure in the late 1980s ...

Israeli tech company Leviticus Cardio has created a unique system that allows for wireless charging of a ventricular assist device (VAD). Previously VADs charged via a power cord that runs from the ...

The use of mechanical support of the circulation with ventricular assist devices for refractory heart failure is increasing. This is due to expanding indications, including for acute heart failure and ...

Patients with cardiogenic shock treated at hospitals with a higher volume of percutaneous microaxial VAD implantation in the US have lower mortality risk. Higher hospital procedure volume of ...

This analysis evaluates the relationship between hospital care delivery network fragmentation and in-hospital and 90-day outcomes. These networks may be novel targets for improving outcomes.

There is no clearly established strategy for the treatment of a patient with cardiomyopathy and a symptomatic aneurysm of the thoracic aorta. We report the successful use of an approach combining ...

Pediatric ventricular assist devices (VADs) and mechanical circulatory support systems have emerged as critical tools in the management of children with end‐stage heart failure, including those with ...

Researchers from the University of South Florida developed a novel ventricular assist device that is placed directly inside a failing ventricular cavity to help it pump blood correctly again. This ...

Please provide your email address to receive an email when new articles are posted on . Medtronic announced it has received a breakthrough device designation from the FDA for its fully implantable ...

Fineheart SA will soon begin a first-in-human study of Flowmaker, its fully implantable left ventricular assist device, in France, after receiving authorization from the French National Agency for the ...

SAN FRANCISCO, CALIF.—Results from a prospective feasibility study demonstrate that the C-Pulse Heart Assist System is both safe and effective in patients with moderate to severe heart failure. The ...